Polygala tenuifolia Willd. Extract delays non-alcoholic fatty liver disease progression in rats via the COX2 and PERK-elF2α-ATF4 pathway
BackgroundNon-alcoholic fatty liver disease (NAFLD), a chronic liver disease posing a severe threat to human health, currently lacks specific therapeutic drugs. Our previous studies have demonstrated that Polygala tenuifolia Willd. Extract (EPT) can significantly suppress the PGE2 inflammatory pathw...
Saved in:
| Main Authors: | Zhiliang Sun, Zhongshi Zhou, Kezheng Liao, Yanju Liu, Yanyun Liu, Chaoyang Wang, Zhihua Zhang, Li Wen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1595752/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Licorice attenuates cisplatin-induced hepatotoxicity by alleviating endoplasmic reticulum stress and apoptosis
by: Jie Li, et al.
Published: (2025-03-01) -
Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer
by: Soo-Yeon Hwang, et al.
Published: (2025-05-01) -
PERK activation mitigates tau pathology in vitro and in vivo
by: Julius Bruch, et al.
Published: (2017-02-01) -
UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2
by: QingShui Wang, et al.
Published: (2025-07-01) -
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
by: Ruize Gao, et al.
Published: (2021-10-01)